Bioject Medical Technologies In (BJCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,302 | -2,016 | -9,081 | -7,010 | -4,836 |
| Depreciation Amortization | 562 | 297 | 852 | 609 | 397 |
| Accounts receivable | -1,529 | -602 | 269 | 178 | 148 |
| Accounts payable and accrued liabilities | 316 | 205 | 144 | -259 | -251 |
| Other Working Capital | -1,284 | -348 | -440 | -418 | -415 |
| Other Operating Activity | 1,658 | 426 | -71 | 321 | 287 |
| Operating Cash Flow | $-3,579 | $-2,039 | $-8,326 | $-6,579 | $-4,670 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,826 | N/A | 5,521 | 4,488 | 2,890 |
| PPE Investments | -747 | -80 | -1,328 | -1,069 | -828 |
| Other Investing Activity | -95 | -16 | 1,275 | -164 | -130 |
| Investing Cash Flow | $984 | $-96 | $5,468 | $3,255 | $1,932 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,100 | N/A | -1,500 | N/A | N/A |
| Debt Issued | N/A | N/A | 3,000 | N/A | N/A |
| Debt Repayment | -607 | -12 | -37 | -160 | -81 |
| Common Stock Issued | 51 | N/A | 173 | 107 | 107 |
| Other Financing Activity | 0 | -333 | 2,178 | 0 | 0 |
| Financing Cash Flow | $544 | $-345 | $3,814 | $-53 | $26 |
| Beginning Cash Position | 3,849 | 3,849 | 2,894 | 2,894 | 2,894 |
| End Cash Position | 1,797 | 1,368 | 3,849 | -483 | 181 |
| Net Cash Flow | $-2,052 | $-2,481 | $955 | $-3,377 | $-2,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,579 | -2,039 | -8,326 | -6,579 | -4,670 |
| Capital Expenditure | -747 | -80 | -1,328 | -1,069 | -828 |
| Free Cash Flow | -4,326 | -2,119 | -9,654 | -7,647 | -5,499 |